| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |